Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab? - Sorbonne Université Access content directly
Journal Articles Lupus Year : 2023

Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?

Fichier principal
Vignette du fichier
Main Document.pdf (178.49 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04080166 , version 1 (03-07-2023)

Identifiers

Cite

Paul Breillat, Alexis Mathian, Flore Rozenberg, Amélie Dutheil, Annick Barbaud, et al.. Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?. Lupus, 2023, 32 (3), pp.453-455. ⟨10.1177/09612033231153536⟩. ⟨hal-04080166⟩
3 View
11 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More